P P Simarro

Summary

Affiliation: World Health Organization
Country: Switzerland

Publications

  1. ncbi Molecular analysis of archived blood slides reveals an atypical human Trypanosoma infection
    Stijn Deborggraeve
    Department of Parasitology, Institute of Tropical Medicine, 2000 Antwerp, Belgium
    Diagn Microbiol Infect Dis 61:428-33. 2008
  2. ncbi Estimating and mapping the population at risk of sleeping sickness
    Pere P Simarro
    Control of Neglected Tropical Diseases, Innovative and Intensified Disease Management, World Health Organization, Geneva, Switzerland
    PLoS Negl Trop Dis 6:e1859. 2012
  3. ncbi Update on field use of the available drugs for the chemotherapy of human African trypanosomiasis
    P P Simarro
    World Health Organization, HTM NTD 20, Avenue Appia 1211, Geneva 27, Switzerland
    Parasitology 139:842-6. 2012
  4. ncbi Human African trypanosomiasis in non-endemic countries (2000-2010)
    Pere P Simarro
    World Health Organization, Control of Neglected Tropical Diseases, Innovative and Intensified Disease Management, Geneva, Switzerland
    J Travel Med 19:44-53. 2012
  5. ncbi Towards the Atlas of human African trypanosomiasis
    Giuliano Cecchi
    Food and Agriculture Organization of the United Nations, Animal Production and Health Division, Rome, Italy
    Int J Health Geogr 8:15. 2009
  6. ncbi Risk for human African trypanosomiasis, Central Africa, 2000-2009
    Pere P Simarro
    World Health Organization, Geneva, Switzerland
    Emerg Infect Dis 17:2322-4. 2011
  7. ncbi The Atlas of human African trypanosomiasis: a contribution to global mapping of neglected tropical diseases
    Pere P Simarro
    World Health Organization, Control of Neglected Tropical Diseases, Innovative and Intensified Disease Management, 1211 Geneva 27, Switzerland
    Int J Health Geogr 9:57. 2010
  8. ncbi Eliminating human African trypanosomiasis: where do we stand and what comes next?
    Pere P Simarro
    World Health Organization, Control of Neglected Tropical Diseases, Innovative and Intensified Disease Management, Geneva, Switzerland
    PLoS Med 5:e55. 2008
  9. ncbi The elimination of Trypanosoma brucei gambiense sleeping sickness in the focus of Luba, Bioko Island, Equatorial Guinea
    P P Simarro
    Sleeping Sickness Control Centre, Bata, Equatorial Guinea
    Trop Med Int Health 11:636-46. 2006
  10. ncbi [Eflornithine in the treatment of African trypanosomiasis]
    F J Louis
    l'Organisation Mondiale de la Sant, , Suisse
    Med Trop (Mars) 63:559-63. 2003

Collaborators

Detail Information

Publications15

  1. ncbi Molecular analysis of archived blood slides reveals an atypical human Trypanosoma infection
    Stijn Deborggraeve
    Department of Parasitology, Institute of Tropical Medicine, 2000 Antwerp, Belgium
    Diagn Microbiol Infect Dis 61:428-33. 2008
    ....
  2. ncbi Estimating and mapping the population at risk of sleeping sickness
    Pere P Simarro
    Control of Neglected Tropical Diseases, Innovative and Intensified Disease Management, World Health Organization, Geneva, Switzerland
    PLoS Negl Trop Dis 6:e1859. 2012
    ....
  3. ncbi Update on field use of the available drugs for the chemotherapy of human African trypanosomiasis
    P P Simarro
    World Health Organization, HTM NTD 20, Avenue Appia 1211, Geneva 27, Switzerland
    Parasitology 139:842-6. 2012
    ..These factors call for continuing research to provide new safer and more effective drugs that are simple to administer and cheaper when compared to current drugs...
  4. ncbi Human African trypanosomiasis in non-endemic countries (2000-2010)
    Pere P Simarro
    World Health Organization, Control of Neglected Tropical Diseases, Innovative and Intensified Disease Management, Geneva, Switzerland
    J Travel Med 19:44-53. 2012
    ..Human African trypanosomiasis (HAT) can affect travelers to sub-Saharan Africa, as well as migrants from disease endemic countries (DECs), posing diagnosis challenges to travel health services in non-disease endemic countries (non-DECs)...
  5. ncbi Towards the Atlas of human African trypanosomiasis
    Giuliano Cecchi
    Food and Agriculture Organization of the United Nations, Animal Production and Health Division, Rome, Italy
    Int J Health Geogr 8:15. 2009
    ..We describe input data, methodology, preliminary results and future prospects of the HAT Atlas initiative, which will allow major improvements in the understanding of the spatial distribution of the disease...
  6. ncbi Risk for human African trypanosomiasis, Central Africa, 2000-2009
    Pere P Simarro
    World Health Organization, Geneva, Switzerland
    Emerg Infect Dis 17:2322-4. 2011
    ..Five risk categories were mapped, and ≈3.5 million persons were estimated to be at risk for this disease...
  7. ncbi The Atlas of human African trypanosomiasis: a contribution to global mapping of neglected tropical diseases
    Pere P Simarro
    World Health Organization, Control of Neglected Tropical Diseases, Innovative and Intensified Disease Management, 1211 Geneva 27, Switzerland
    Int J Health Geogr 9:57. 2010
    ..For this reason WHO launched the HAT Atlas initiative, jointly implemented with the Food and Agriculture Organization of the United Nations, in the framework of the Programme Against African Trypanosomosis...
  8. ncbi Eliminating human African trypanosomiasis: where do we stand and what comes next?
    Pere P Simarro
    World Health Organization, Control of Neglected Tropical Diseases, Innovative and Intensified Disease Management, Geneva, Switzerland
    PLoS Med 5:e55. 2008
  9. ncbi The elimination of Trypanosoma brucei gambiense sleeping sickness in the focus of Luba, Bioko Island, Equatorial Guinea
    P P Simarro
    Sleeping Sickness Control Centre, Bata, Equatorial Guinea
    Trop Med Int Health 11:636-46. 2006
    ..First-stage cases were treated with pentamidine and second-stage cases with melarsoprol. A few relapses and very advanced cases were treated with eflornithine. The last sleeping sickness case was identified and treated in 1995...
  10. ncbi [Eflornithine in the treatment of African trypanosomiasis]
    F J Louis
    l'Organisation Mondiale de la Sant, , Suisse
    Med Trop (Mars) 63:559-63. 2003
  11. ncbi [The concept of neglected disease]
    J Jannin
    Organisation mondiale de la Sante, CDS CPE ZFK, 20 Avenue Appia, 1211 Genève 27, Suisse
    Med Trop (Mars) 63:219-21. 2003
    ..The effects of this campaign are now beginning to be felt...
  12. ncbi Effectiveness of a 10-day melarsoprol schedule for the treatment of late-stage human African trypanosomiasis: confirmation from a multinational study (IMPAMEL II)
    Caecilia Schmid
    Swiss Tropical Institute, Basel
    J Infect Dis 191:1922-31. 2005
    ..The shorter protocol has been recommended by the International Scientific Council for Trypanosomiasis Research and Control for the treatment of late-stage HAT caused by Trypanosoma brucei gambiense...
  13. ncbi [The efficiency of different detection strategies of human African trypanosomiasis by T. b. gambiense]
    Pascal Lutumba
    Programme National de Lutte contre la Trypanosomiase Humaine Africaine, Kinshasa, Republique Democratique du Congo
    Trop Med Int Health 10:347-56. 2005
    ..This decision analysis compared the efficiency of three alternative detection strategies: screening by LN only, CATT only and their combination (LN and CATT)...
  14. ncbi Control of human African trypanosomiasis in the Quiçama focus, Angola
    Jose Antonio Ruiz
    Agencia Espanola de Coopercion International, Muxima Health Centre, Muxima, Angola
    Bull World Health Organ 80:738-45. 2002
    ..To update the epidemiological status of human African trypanosomiasis (HAT), also known as sleeping sickness, in the Quiçama focus, province of Bengo, Angola, and to establish a HAT control programme...
  15. ncbi Real-time PCR for detection of Trypanosoma brucei in human blood samples
    Sven Becker
    School of Biological Sciences, University of Bristol, Bristol, United Kingdom
    Diagn Microbiol Infect Dis 50:193-9. 2004
    ..The results indicate that the real-time PCR assay described is a rapid and sensitive method suitable for the detection of T. brucei in human blood samples in routine clinical laboratory practice...